Revista Española de Enfermedades Digestivas
Síguenos en
Sociedad Española de Patología Digestiva
FI (2021) JCR: 2,389 / SJR: 0,3 (Q3)
Versión castellanoVersión Castellano
English versionEnglish version
Year 2022 / Volume 114 / Number 6
Submission and tracking of manuscripts
Instructions to authors

Submission and tracking

REED Journal

REED Journal

Play video

Year 2022 / Volume 114 / Number 6

Letter

Infliximab-induced hypoglycemia, a rare but relevant side effect

364-365

Lucía Zabalza, Joaquín de Carlos, Iranzu Ezcurra, María Rullán, Alfonso Elosua, Saioa Rubio, Lluis Forga, Cristina Rodríguez,

Tumor necrosis factor (TNF) inhibitors are part of the therapeutic arsenal for many immune-mediated diseases and, especially in inflammatory bowel disease (IBD), have led to a change in the management of this disease.

Reader rating: Rate this article:
Share Button
Send by e-mail

New comment


Security code:
CAPTCHA code image
Speak the codeChange the code
 

Comments

No hay comentarios para este artículo.
Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Privacy Policy
© 2022 The Spanish Journal of Gastroenterology


In accordance with current legislation, this publication is only for health care professionals.